Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Osteonic Co. Ltd. (226400:KRX), powered by AI.
Osteonic Co. Ltd. is currently trading at ₩4,575. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Osteonic Co. Ltd. on Alpha Lenz.
Osteonic Co. Ltd.'s P/E ratio is 12.6.
“Osteonic Co. Ltd. trades at a P/E of 12.6 (undervalued) with solid ROE of 11.8%. 3Y revenue CAGR of 31.8% highlights clear growth momentum.”
Ask for details →Osteonic Co. Ltd. is a leading company in the medical device industry, specializing in the design, manufacture, and distribution of orthopedic surgical implants and instruments. Its primary function is to provide high-quality, innovative solutions for orthopedic surgeries, which are crucial for treating musculoskeletal conditions and injuries. Serving both local and international markets, Osteonic Co. Ltd. plays a vital role in the healthcare sector by enabling surgeons to perform efficient and effective surgical procedures, thereby improving patient outcomes. The company's diverse product portfolio includes a range of implants such as bone plates, screws, and joint replacement systems, catering to various specialties within orthopedics like spine, trauma, and reconstructive surgeries. By focusing on research and development, Osteonic Co. Ltd. continuously advances its technology to meet the evolving needs of the medical community and enhance patient care. In the financial market, the company holds significant importance as a distinguished provider within the medical sector, contributing to advancements in healthcare through its commitment to innovation and quality assurance."}iventified in the following: 2290 in the body. 2290 in the synonym.
“Osteonic Co. Ltd. trades at a P/E of 12.6 (undervalued) with solid ROE of 11.8%. 3Y revenue CAGR of 31.8% highlights clear growth momentum.”
Ask for details →Osteonic Co. Ltd. (ticker: 226400) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 185 employees. Market cap is $94.5B.
The current price is ₩4,575 with a P/E ratio of 12.61x and P/B of 1.4x.
ROE is 11.83% and operating margin is 19.53%. Annual revenue is $45.4B.